DS-ALL also likely stems from perturbed lymphopoiesis, which begins in utero, and is characterized by CRLF2/TSLPR overexpression in 50% and JAK2 mutations in 20% (Li et al., 2023). Here, CRLF2 is linked to Dravet syndrome.